Health

Results: 145-156 of 9481

PR Newswire associated0

MOYOM Advances European Regenerative Aesthetics Through APHRANEL® EU MDR Certification and Strategic Scientific Collaboration with Expert2Expert

IMPACT Therapeutics Signs Exclusive License Agreement with Pharmanovia for Senaparib in Europe, Middle East and North Africa, Australia and New Zealand

Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate

PR Newswire associated0

Proteotype Unveils Alchemi®, the Data and Orchestration Platform Behind Enlighten®

One Biosciences Announces Data Validating New Method for Single-Cell Transcriptomic Tumor Profiling from Clinical Pathology Samples

PR Newswire associated0

Proteotype Launches €3 Million European Study to Advance Multi-Cancer Detection and Evaluate Home Blood Collection

PR Newswire associated0

Continuity Biosciences Appoints Vicky Papoutsis to Board of Directors

White Paper Examines Early Clinical Development of B-Cell Depletion Therapies in Autoimmune Disease

Ping An Group Upgrades Longevity Management Service System, Unveils 11 Health Longevity Centers Nationwide

Takeda Announces FY2026 First Quarter Results, Near-Term Launch Preparations and Pipeline Progress on Track

Iksuda receives US FDA IND clearance for IKS04